Revolutionizing Atopic Dermatitis (RAD) Virtual Conference - Sunday, December 10, 2023 - 1:00pm - 6:00pm (ET)

Although diagnosis of Atopic Dermatitis (AD) is straightforward in children, its diagnosis is challenging in adults. Advances in research on AD epidemiology, burden and comorbidities have transformed the understanding of the course of AD, including risk factors, age of onset, disease severity and persistence, and health outcomes. Clinicians may not be aware of the epidemiology of AD for proper risk stratification, patient education and therapeutic decision-making. Atopic dermatitis is a heterogeneous disorder with variable severity of signs and symptoms, and impact on quality of life. Clinicians may not be able to assess AD severity accurately in order to optimize therapy. Our Conference allows clinicians to understand this disease better through the latest in research, expert faculty speakers, late-breaking research and Q&A sessions.

Please note that you will not receive an email confirming registration until after the fee has been paid. If you have a discount code, please enter the code when registering. Once you do so and complete the required registration information, you will receive a confirmation email.

Registration Rates - Virtual Conference

Designation
Early-Bird Rates
September 1 - November 1, 2023
November 2, 2023 -
Day of Program
Physicians and Fellows $50 $75
Nurses and PAs $50 $75
Residents and Students Free Free
Industry $300 $500
Patients Free Free

If you are a patient, caregiver, student or member of the media, and you are interested in attending the Conference, please contact Patrice Melluso: patrice@revolutionizingad.com

If you registered for the program and did not receive your registration confirmation email, please check your spam/junk folder. If you are unable to find the email, please email Donna Jimenez: djimenez@dnadigitalgroup.com

 

Target Audience

This program is intended for dermatologists, allergists and immunologists, primary care clinicians, NPs/RNs/APRNs, physician assistants and other allied health professionals as well as patients/patient groups engaged in the care of patients with Atopic Dermatitis (AD).

Educational Objectives

After completing this activity, the participant should be better able to:

  • Discuss improved understanding of pathophysiology, disease course and current, available treatment options in therapeutic decision making for atopic dermatitis and related comorbidities
  • Identify best-practice in therapeutics for atopic dermatitis
  • Incorporate new and emerging therapeutics into the management of atopic dermatitis

Joint Accreditation Statement

       

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Revolutionizing Atopic Dermatitis. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this live activity for a maximum 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 4 contact hours.

AAPACONTINUING PHYSICIAN ASSISTANT EDUCATION
Postgraduate Institute for Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.